For: | Yu HS, Jiang H, Li MK, Yang BL, Smayi A, Chen JN, Wu B, Yang YD. Lowering the threshold of alanine aminotransferase for enhanced identification of significant hepatic injury in chronic hepatitis B patients. World J Gastroenterol 2023; 29(35): 5166-5177 [PMID: 37744292 DOI: 10.3748/wjg.v29.i35.5166] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i35/5166.htm |
Number | Citing Articles |
1 |
Zi-Hong Bao, Zhi-Kun Dai, Hao-Xian Tang. Antiviral treatment standards for hepatitis B: An urgent need for expansion. World Journal of Gastroenterology 2024; 30(4): 418-420 doi: 10.3748/wjg.v30.i4.418
Abstract(108) |
Core Tip(121) |
Full Article(HTML)(502)
|
Full Article with Cover (PDF)-770K(24)
|
Full Article (Word)-104K(11)
|
Audio-627K(4)
|
Peer-Review Report-197K(18)
|
Answering Reviewers-80K(20)
|
Full Article (PDF)-336K(58)
|
Full Article (XML)-30K(16)
|
Times Cited (1)
|
Total Visits (1243)
|
Open
|
2 |
Yen-Chun Liu, Wen-Juei Jeng. Should Indications for Antiviral Therapy for Hepatitis B Be Broadened to Include Immune-Tolerant Patients, Inactive Carriers, or Patients in the “Gray Zone”?. Current Hepatology Reports 2024; 23(1): 11 doi: 10.1007/s11901-024-00635-w
|
3 |
Yuhua Gao, Mingyang Wang, Xia’nan Liu, Benjamin M. Liu. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase. Microbiology Spectrum 2024; 12(4) doi: 10.1128/spectrum.03941-23
|